Chimerix, Inc.
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is …
Biotechnology
US, Durham [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Chimerix, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDChimerix, Inc. can't present revenue by segment